Last update 14 Jun 2025

90Y-IDEC-159

Overview

Basic Info

Drug Type
Radiolabeled antibody, Therapeutic radiopharmaceuticals
Synonyms-
Target
TAG-72
Action
inhibitors
Mechanism
Tumor-associated glycoprotein 72 inhibitors, Ionising radiation emitters
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication-
Inactive Indication
Metastatic Colorectal CarcinomaNeoplasm Metastasis
Originator Organization
Biogen, Inc.Biogen, Inc.
Active Organization-
Inactive Organization
Biogen, Inc.Biogen, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with 90Y-IDEC-159
NCT00102024
/ TerminatedPhase 1/2
A Phase I/II, Open-Label, Dose-Escalation Study to Evaluate the Safety and Activity of Single Dose 90Y-Labeled IDEC-159, Humanized, Domain Deleted, Anti TAG-72 Monoclonal Antibody, in Subjects With Metastatic Colorectal Adenocarcinoma
100 Clinical Results associated with 90Y-IDEC-159
Login to view more data
100 Translational Medicine associated with 90Y-IDEC-159
Login to view more data
100 Patents (Medical) associated with 90Y-IDEC-159
Login to view more data
100 Deals associated with 90Y-IDEC-159
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Colorectal CarcinomaPhase 2
United States
Biogen, Inc.Biogen, Inc.
01 Jan 2005
Neoplasm MetastasisPhase 2
United States
Biogen, Inc.Biogen, Inc.
01 Jan 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
ASTRO2010
Not Applicable
Metastatic Colorectal Carcinoma
-
IDEC-159
dmktvqmhel(vecgwndqui) = xjzkbcvpyi mnlmbjzydb (yjstvvorli, 31.7 - 39.7)
-
01 Nov 2010
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free